COMMUNIQUÉS West-GlobeNewswire

NMDP Named ‘Best Place to Work’ Fourth Year in a Row

23/08/2024 - 18:58

Global cell therapy nonprofit honored in top 3 of the 'extra large' companies, recognizing its exceptional employees, workplace culture and life-saving mission MINNEAPOLIS, Aug. 23, 2024 (GLOBE NEWSWIRE) -- NMDP SM , a [...]

Sienna Files Final Short Form Prospectus in Connection with Bought Deal Equity Financing and Obtains Receipt of Final Prospectus

23/08/2024 - 18:54

Final Short Form Prospectus is Accessible on SEDAR+ NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc [...]

Fagron’s share buy-back program: Weekly update

23/08/2024 - 18:45

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 23 August 2024 – 6PM CET Fagron’s share buy-back program: Weekly update In the period from 19 August 2024 through 23 August 2024, Fagron purchased 34 [...]

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

23/08/2024 - 18:00

COPENHAGEN, Denmark, August 23, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial [...]

Eyenovia Announces Closing of Public Offering

23/08/2024 - 17:42

NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (“Eyenovia” or the “Company”) (NASDAQ: EYEN), a commercial-stage ophthalmic company, announced today the closing of its public offering of 12,850,000 shares of [...]

Thermo Scientific™ VisionMate™ HSX High Speed Barcode Reader Integrates with eLabNext Platform

23/08/2024 - 17:33

BOSTON, Aug. 23, 2024 (GLOBE NEWSWIRE) -- eLabNext , an Eppendorf Group Company offering a flexible Digital Laboratory Platform equipped with a Laboratory Inventory Management System (LIMS) and Electronic Lab Notebook ( [...]

Vistin Pharma ASA: Mandatory notification of trade

23/08/2024 - 16:06

Saga Pure ASA has on 23 August 2024 purchased 300,000 shares in Vistin Pharma ASA at NOK 22,50 per share. After the transaction Saga Pure ASA has a holding of 400,000 shares, corresponding to 0.9 % ownership. Saga Pure [...]

BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA OPERATIONS, LLC. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.

23/08/2024 - 16:00

GRANTS, NEW MEXICO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”) today announced that it has signed a letter of intent to supply its DEA-approved marijuana [...]

Wendy Vlieks Appointed as President of The Genome Partnership, Succeeding Leisa Zigman

23/08/2024 - 16:00

Experienced Communications Leader to Drive Growth and Educational Initiatives ST. LOUIS, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The Genome Partnership is pleased to announce the appointment of Wendy Vlieks, former VP of [...]

Altamira Therapeutics Announces Extension of Bentrio Distribution Agreement with Pharma Nordic to Include Sweden and Denmark

23/08/2024 - 15:01

Hamilton, Bermuda, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Successful launch of Bentrio by Pharma Nordic AS in Norway in 2024 Exclusive distribution agreement extended to also include Sweden and Denmark Altamira Therapeutics [...]

OKYO Pharma CEO Interview to Air on Bloomberg TV

23/08/2024 - 15:00

LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye [...]

CytoDyn Engages Leading CRO For Phase II Inflammation Trial

23/08/2024 - 14:30

VANCOUVER, Washington, Aug. 23, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple [...]

Le KFSHRC établit de nouvelles normes mondiales en matière de technologie de RV à l’occasion de la conférence AMEE 2024

23/08/2024 - 14:15

RIYAD, Arabie saoudite, 23 août 2024 (GLOBE NEWSWIRE) -- En adoptant sans cesse de nouvelles technologies, le KFSHRC veille à ce que ses apprenants disposent des compétences et des connaissances nécessaires pour relever [...]

WORK Medical Technology Group LTD Announces Pricing of Initial Public Offering

23/08/2024 - 14:00

Hangzhou, China, Aug. 23, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (the "Company"), a supplier of medical devices in China, today announced the pricing of the initial public offering (the "Offering") [...]

European Commission approves BALVERSA®▼ (erdafitinib) for adult patients with unresectable or metastatic urothelial carcinoma

23/08/2024 - 13:30

First pan FGFR kinase inhibitor to be approved in the European Economic Area, for adults with unresectable or metastatic urothelial carcinoma and susceptible FGFR 3 alterations Approval based on THOR results, showing 36 [...]

Repligen Corporation to Present at Wells Fargo Healthcare Conference

23/08/2024 - 13:30

WALTHAM, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at the Wells Fargo [...]

OKYO Pharma Announces Chairman Acquires Shares

23/08/2024 - 13:00

LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye [...]

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

23/08/2024 - 13:00

CALGARY, Alberta, Aug. 23, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing [...]

AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema

23/08/2024 - 13:00

Novel JEL™ Technology for Periocular Administration COSTA MESA, Calif., Aug. 23, 2024 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has fully enrolled and completed [...]